So if someone writes you a check
funded by drug sales, then you have to worry about the reason for the check.
And the general problems of research
funded by drug companies are real enough.
She's Dating the Gangster is a 2014 Filipino teen romantic comedy - drama film based on the best Pop Fiction book of the same name originally published on A gangster's ex-wife has been spared jail after she told a court she had no idea her luxury life was
funded by his drug money.
Identifying Conflicts of Interest I realize that it's important to present both sides of an issue, but Dr. Wulf Utian and his North American Menopause Society (NAMS) are
funded by the drug industry, and in particular by those whose bottom line is most threatened by bioidentical hormones.
The new study was
funded by drug maker Novartis.
Until these review articles appeared, assumptions about the effectiveness of drugs were based only on published studies — ones which were largely
funded by drug companies.
He wasn't involved in the new study, which was
funded by drug maker Janssen.
Begun in April 2010, it was
funded by the drug's manufacturer, Merck of Whitehouse Station, N.J.
Called the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) and
funded by the drug giant Novartis, the trial also found fewer cases of lung cancer in those on the treatment, rekindling basic research findings hinting that the same inflammatory pathway may initiate or spur the growth of such tumors.
Although these facts do not mean that the results are invalid, a 2003 study published in the British Medical Journal suggests that trials
funded by drug companies are more likely to report favorable results about their products than are trials funded by independent organizations.
Medical research must be funded in some way, and if it's funded by cosmetic companies, I honestly sometimes think that's better than it being
funded by drug companies who push pill after pill regardless of the consequences.
Not exact matches
«We have an agreement with them where we own the
drug, but anything that's
funded by the U.S. government, it reserves the right to use that under certain circumstances,» says Mark Murray, president and CEO of the Burnaby, B.C., company.
Since it takes several rounds of discussions to understand something as complicated as
drug development, this was a boon to fledgling biopharma companies, and VC
funding in the space was booming
by 2013.
Phase I
funding — which allows up to $ 250,000 for an academic idea, such as decoding the genetic sequence of a protein or studying targeted
drug delivery
by using magnetic nanoparticles — is available from federal
funding and foundations.
(This was
funded by a job selling In - N - Out burgers, and legal because the product is a nutritional supplement, not actually a
drug.)
U.S. drugmaker Turing Pharmaceuticals, led at the time
by hedge
fund manager Martin Shkreli, caused outrage last year
by raising the U.S. price of Daraprim, an old anti-infective
drug,
by more than 5,000 % to $ 750 a pill.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of
funding for state AIDS
Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the S
Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven
by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused
by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held
by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new
drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the S
drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
And because individual states could still prohibit marijuana locally, Booker's bill would also incentivize states to change their marijuana laws
by withholding federal
funding from any states that have enforced laws against the
drug in ways that disproportionately affect low - income citizens and people of color.
• Oculis, an Iceland - based developer of a solubilizing nanoparticle
drug delivery platform, has raised an undisclosed amount of Series A
funding co-led
by Brunner Ventures and Silfuberg.
Located in South San Francisco, Calif., and
funded by leading investors, including The Column Group (TCG), Kleiner Perkins (KP), Topspin Partners, GV and Celgene Corporation, we have assembled a leadership team and advisory group with a proven track record of success and team of scientists with substantial knowledge and expertise in
drug discovery and translational areas essential to execute on this approach.
Reduces surging crime,
drugs and violence
by creating a Task Force On Violent Crime and increasing
funding for programs that train and assist local police; increases resources for federal law enforcement agencies and federal prosecutors to dismantle criminal gangs and put violent offenders behind bars.
In an email he sent Ackman, who is one of the world's best - known hedge
fund managers, was a link to Hempton's latest critique of the Canadian
drug maker's potential problems, one of the most detailed produced
by anyone yet.
Located in South San Francisco, Calif., and
funded by leading investors, including The Column Group (TCG), Kleiner Perkins (KP), Topspin Partners, GV (formerly Google Ventures) and Celgene Corporation, FLX Bio has assembled a leadership team and advisory group with a proven track record of success and team of scientists with substantial knowledge and expertise in
drug discovery and translational areas essential to execute on this approach.
The
drug, called Daraprim, was acquired in August
by Turing Pharmaceuticals, a start - up run
by a former hedge
fund manager.
He started MSMB Capital, a hedge
fund company, in his 20s and drew attention for urging the Food and
Drug Administration not to approve certain
drugs made
by companies whose stock he was shorting.
A newly formed company, it's
funded by investors including the specialty
drug company...
Directing emergency
funds to areas hit
by natural disasters had traditionally been quick bipartisan exercises, but that changed after Hurricane Katrina in 2005 — when the Republican Study Committee, a group of House conservatives, pushed spending cuts to compensate for the approximately $ 200 billion expected in Katrina relief — including cutting farm subsidies, Amtrak
funding and postponing the Medicare prescription -
drug bill Republicans had approved two years earlier.
Cryptocurrency enthusiasts on Reddit defended cryptocurrencies
by saying that even plain cash can be used for
funding terror activities and for buying
drugs.
Drugs are a huge problem here, and we have no desire to help people destroy their lives
by helping them
fund their purchases of crystal, crack, and similar substances.
With the right
funding commitments in place, the Global
Fund can help ensure that no child is born with HIV
by 2015, that we end the public health threat of malaria as we know it, and emerging
drug resistant strains of TB are brought under control.»
Run
by radicals for approximately twenty years, Berkeley has experienced the virtual ruin of its public school system, a vastly increased municipal bureaucracy, a greatly diminished housing stock (thanks to stringent rent controls and other restrictions on property rights), increased crime and
drug abuse, widespread corruption, and wholesale waste of public
funds.
Founded in 1998
by Leonard A. and Ronald S. Lauder, the ADDF provides critical seed
funding to leading scientists conducting breakthrough
drug discovery and clinical research.
The FDA is suppose to monitor «research» on food and
drugs and yet is largely
funded by the pharmaceutical companies.
If however many MDs aren't practicing evidence - based medicine, then why not don't MDs * police their own * before going off on other professions for their lack of evidence - base... or attacking what evidence - base there is even if it isn't multiple double - blind placebo controlled studies
funded by wealthy
drug manufacturers?
I'm confused
by the reference to the «Food and
Drug Administration» in the second entry (it's the Department of Agriculture that oversees child nutrition), but the intent of these lawmakers is clear: destroy all of the tremendous progress we've made over the last six years in improving our children's school food environment, and apparently also the food served in federally
funded daycare centers.
Funding / Support: The Infant Feeding Practices Study II was
funded by the Food and
Drug Administration, Centers for Disease Control and Prevention, Office of Women's Health, National Institutes of Health, and Maternal and Child Health Bureau in the US Department of Health and Human Services.
For the purposes of this economic evaluation, the forms were initially used in a related study
funded by the National Institute of Health Research (NIHR) research for patient benefit programme «assessing the impact of a new birth centre on choice and outcome of maternity care in an inner city area,» which will be reported in full elsewhere, comparing the costs of care in a free standing midwifery unit with care in an obstetric unit in the same trust.16 The data collected included details of staffing levels, treatments, surgeries, diagnostic imaging tests, scans,
drugs, and other resource inputs associated with each stage of the pathway through intrapartum and after birth care.
The research was
funded by the Eunice Kennedy Shriver National Institute of Child Health & Human Development, the National Institute on
Drug Abuse, and the National Institute of Mental Health.
On the other hand we are fighting the war on terror which is largely
funded by this war on
drugs.
We would be able to protect millions if not billions of people around the planet who have been ravaged not just
by the
drug war, crimes and the vicious violence but also
by terrorist groups
funded largely
by this trade who continue to maim and kill around the planet too.»
Russia takes the lead on preventing
drug law reform at the UN, after the US
funds itself compromised
by the Colorado cannabis experiment
A member of a three - man robbery gang, arrested weekend
by operatives of the Rapid Response Squad, RRS, of Lagos State Command, has said that he went into robbery to raise
funds for his diabetes
drugs.
However, the actual language of this bill has the $ 127 million being deposited into the state's general
fund, while the state's overall spending on alcohol and
drug treatment will only increase
by $ 18 million.
A former aide to Hillary ClintonHillary Diane Rodham ClintonTrump Jr. met with Gulf adviser who offered help to win election: report Voters Dems need aren't impressed
by anti-waterboarding showboating After year of investigation, Trump can rightly claim some vindication MORE criticized Sen. Kirsten GillibrandKirsten Elizabeth GillibrandOvernight Health Care — Sponsored
by PCMA — Trump hits federally
funded clinics with new abortion restrictions Dem senators ask
drug companies to list prices in ads Gillibrand to publish children's book about suffragists MORE on Thursday after the New York Democrat became the first of many senators to join a successful push to force the resignation of Sen. Al FrankenAlan (Al) Stuart Franken100 days after House passage, Gillibrand calls on Senate to act on sexual harassment reform Eric Schneiderman and #MeToo pose challenges for both parties Senate confirms Trump judicial pick over objections of home - state senator MORE (D - Minn.).
The so - called «Pharma Bro,» notorious for raising the price of a potentially life - saving
drug by 5,000 percent, was found guilty today of defrauding investors in two hedge
funds and in Retrophin Inc., a pharmaceutical company he co-founded.
Gov. Dannel P. Malloy released a revised budget Monday that would cut state
funding to cities and towns
by $ 362 million more than his original proposal and would increase taxes on nonprescription
drugs and the sale of mansions.
«I think we understand some things happened that should not have happened,» said Senate Democratic Whip Dick DurbinRichard (Dick) Joseph DurbinOvernight Health Care — Sponsored
by PCMA — Trump hits federally
funded clinics with new abortion restrictions Dem lawmaker spars with own party over prison reform Dem senators ask
drug companies to list prices in ads MORE (Ill.).
(Posted 24 December 2011) Significant current scandals, and those yet to come In no particular order Top salaries and bonuses - boardroom and shareholder individual responsibility The multiple between top and average pay Lawyers fees - the cost of the legal process Medical negligence claims against the NHS Care and treatment in the NHS «No win, no fee» personal injury compensation Democracy and the voting system Lords reform Political party
funding The domestic energy market and pricing The Tax system and its inefficiencies and complexities Subsidies for new energy generation schemes The amount of crime fuelled
by Drugs The availability of drugs in pr
Drugs The availability of
drugs in pr
drugs in prison.
He said a cannabis survey was being conducted
by the United Nations Office on
Drugs and Crime (UNODC) under the European Union (EU)
funded project in collaboration with the Nigerian Government and technical support from the Nigerian Air Force.
A free portable kit with condoms, lubricant and a section for pills, which health officials hope those at high risk for contracting H.I.V. will use to carry the preventive
drug Truvada — will be distributed
by NYC (and through clinics that receive municipal
funds) early next year.